329 related articles for article (PubMed ID: 22841809)
1. Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii.
Karah N; Sundsfjord A; Towner K; Samuelsen Ø
Drug Resist Updat; 2012 Aug; 15(4):237-47. PubMed ID: 22841809
[TBL] [Abstract][Full Text] [Related]
2. Clonal complexes 104, 109 and 113 playing a major role in the dissemination of OXA-carbapenemase-producing Acinetobacter baumannii in Southeast Brazil.
Clímaco EC; Oliveira ML; Pitondo-Silva A; Oliveira MG; Medeiros M; Lincopan N; da Costa Darini AL
Infect Genet Evol; 2013 Oct; 19():127-33. PubMed ID: 23838284
[TBL] [Abstract][Full Text] [Related]
3. A diversity of OXA-carbapenemases and class 1 integrons among carbapenem-resistant Acinetobacter baumannii clinical isolates from Sweden belonging to different international clonal lineages.
Karah N; Giske CG; Sundsfjord A; Samuelsen Ø
Microb Drug Resist; 2011 Dec; 17(4):545-9. PubMed ID: 21830948
[TBL] [Abstract][Full Text] [Related]
4. Identification of multidrug- and carbapenem-resistant Acinetobacter baumannii in Canada: results from CANWARD 2007.
McCracken M; DeCorby M; Fuller J; Loo V; Hoban DJ; Zhanel GG; Mulvey MR
J Antimicrob Chemother; 2009 Sep; 64(3):552-5. PubMed ID: 19578083
[TBL] [Abstract][Full Text] [Related]
5. Evolution of multidrug-resistant Acinetobacter baumannii clonal lineages: a 10 year study in Greece (2000-09).
Gogou V; Pournaras S; Giannouli M; Voulgari E; Piperaki ET; Zarrilli R; Tsakris A
J Antimicrob Chemother; 2011 Dec; 66(12):2767-72. PubMed ID: 21933784
[TBL] [Abstract][Full Text] [Related]
6. [Molecular epidemiological characteristics of clinically isolated carbapenem-resistant Acinetobacter baumannii in Changsha].
Liang W; Zou M; Wu J; Wu G; Li J; Dou Q; Liu W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 May; 37(5):521-6. PubMed ID: 22659652
[TBL] [Abstract][Full Text] [Related]
7. Molecular Epidemiology and Mechanisms of Carbapenem Resistance of Acinetobacter spp. in Asia and Oceania.
Kamolvit W; Sidjabat HE; Paterson DL
Microb Drug Resist; 2015 Aug; 21(4):424-34. PubMed ID: 25714653
[TBL] [Abstract][Full Text] [Related]
8. Emergence and spread of carbapenem-resistant strains of Acinetobacter baumannii in a tertiary-care hospital in Poland.
Wroblewska MM; Towner KJ; Marchel H; Luczak M
Clin Microbiol Infect; 2007 May; 13(5):490-6. PubMed ID: 17331123
[TBL] [Abstract][Full Text] [Related]
9. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.
Poirel L; Nordmann P
Clin Microbiol Infect; 2006 Sep; 12(9):826-36. PubMed ID: 16882287
[TBL] [Abstract][Full Text] [Related]
10. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterisation of multiple drug-resistant Acinetobacter baumannii isolates in southern Taiwan.
Ben RJ; Yang MC; Hsueh JC; Shiang JC; Chien ST
Int J Antimicrob Agents; 2011 Nov; 38(5):403-8. PubMed ID: 21871784
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina.
Brown S; Young HK; Amyes SG
Clin Microbiol Infect; 2005 Jan; 11(1):15-23. PubMed ID: 15649299
[TBL] [Abstract][Full Text] [Related]
13. Sequential outbreaks of multidrug-resistant Acinetobacter baumannii in intensive care units of a tertiary referral hospital in Italy: combined molecular approach for epidemiological investigation.
Ansaldi F; Canepa P; Bassetti M; Zancolli M; Molinari MP; Talamini A; Ginocchio F; Durando P; Mussap M; Orengo G; Viscoli C; Icardi G
J Hosp Infect; 2011 Oct; 79(2):134-40. PubMed ID: 21820758
[TBL] [Abstract][Full Text] [Related]
14. Temporal evolution of carbapenem-resistant Acinetobacter baumannii in Curitiba, southern Brazil.
Schimith Bier KE; Luiz SO; Scheffer MC; Gales AC; Paganini MC; Nascimento AJ; Carignano E; Dalla Costa LM
Am J Infect Control; 2010 May; 38(4):308-14. PubMed ID: 20123152
[TBL] [Abstract][Full Text] [Related]
15. Molecular epidemiology of carbapenem-non-susceptible Acinetobacter baumannii in Japan.
Endo S; Yano H; Hirakata Y; Arai K; Kanamori H; Ogawa M; Shimojima M; Ishibashi N; Aoyagi T; Hatta M; Yamada M; Tokuda K; Kitagawa M; Kunishima H; Kaku M
J Antimicrob Chemother; 2012 Jul; 67(7):1623-6. PubMed ID: 22447879
[TBL] [Abstract][Full Text] [Related]
16. AbaR4 replaces AbaR3 in a carbapenem-resistant Acinetobacter baumannii isolate belonging to global clone 1 from an Australian hospital.
Hamidian M; Hall RM
J Antimicrob Chemother; 2011 Nov; 66(11):2484-91. PubMed ID: 21873287
[TBL] [Abstract][Full Text] [Related]
17. Imipenem: a potent inducer of multidrug resistance in Acinetobacter baumannii.
Kuo HY; Chang KC; Kuo JW; Yueh HW; Liou ML
Int J Antimicrob Agents; 2012 Jan; 39(1):33-8. PubMed ID: 21996406
[TBL] [Abstract][Full Text] [Related]
18. Carbapenem-resistant Acinetobacter baumannii producing OXA-23 in Thailand.
Niumsup PR; Boonkerd N; Tansawai U; Tiloklurs M
Jpn J Infect Dis; 2009 Mar; 62(2):152-4. PubMed ID: 19305059
[TBL] [Abstract][Full Text] [Related]
19. Two distinct clones of carbapenem-resistant Acinetobacter baumannii isolates from Korean hospitals.
Park YK; Choi JY; Jung SI; Park KH; Lee H; Jung DS; Heo ST; Kim SW; Chang HH; Cheong HS; Chung DR; Peck KR; Song JH; Ko KS
Diagn Microbiol Infect Dis; 2009 Aug; 64(4):389-95. PubMed ID: 19631092
[TBL] [Abstract][Full Text] [Related]
20. Carbapenem-hydrolyzing oxacillinase in high resistant strains of Acinetobacter baumannii isolated from India.
Tiwari V; Kapil A; Moganty RR
Microb Pathog; 2012 Aug; 53(2):81-6. PubMed ID: 22610043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
